These results imply that CD80, CD86 and AXL may be responsible for protecting pancreatic cancer non-stem cells from immune clearance while CEACAM5 disrupts immune clearance of cancer stem cells. The gene discussed is AXL; the disease is familial pancreatic carcinoma.